PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
Giuseppe Ercolano(University of Geneva), Camilla Jandus(Ludwig Cancer Research)
Cited by 82
Related Papers
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
|Nature Communications|2017|224